NEJM Interviews
NEJM Group
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
Episodes
Mentioned books
Jan 18, 2012 • 11min
NEJM Interview: Cynthia Jackevicius on generic drugs and health care costs.
Cynthia Jackevicius is an associate professor of pharmacy practice at Western University of Health Sciences in Pomona, California, and an assistant professor in the Department of Health Policy, Management and Evaluation at the University of Toronto. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.A. Jackevicius et al. Generic Atorvastatin and Health Care Costs. N Engl J Med 2012;366:201-4.
Jan 11, 2012 • 19min
NEJM Interview: I. Glenn Cohen on the constitutional challenge of the Affordable Care Act that will heard by the United States Supreme Court in March.
I. Glenn Cohen is an Assistant Professor and Co-Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, both at Harvard Law School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. I.G. Cohen and J.F. Blumstein. The Constitutionality of the ACA's Medicaid-Expansion Mandate. N Engl J Med 2012;366:103-4.
Jan 4, 2012 • 22min
NEJM Interview: Allan Brandt on the history of the Journal as a window into the history of medicine, science, and society.
Allan Brandt is a Professor of the History of Medicine at Harvard Medical Schooland Dean of the Graduate School of Arts and Sciences at Harvard University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Brandt A. A Reader's Guide to 200 Years of the New England Journal of Medicine. N Engl J Med 2012;366:1-7.
Dec 21, 2011 • 13min
NEJM Interview: Dr. Robert Schwartz on the history of cancer research.
Dr. Robert Schwartz is a professor emeritus of medicine at Tufts Medical School, and a former deputy editor at the Journal, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Schwartz R. The Emperor of All Maladies - The Beginning of the Beginning. N Engl J Med 2011;365:2353-5.
Dec 14, 2011 • 16min
NEJM Interview: Dr. Elliot Israel on the risks and benefits of long-acting beta agonists in the treatment of asthma and COPD.
Dr. Elliot Israel is a Professor of Medicine at Harvard Medical School and the Director of Clinical Research in the Pulmonary and Critical Care Division at Brigham and Women's Hospital, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Chowdhury B et al. The Risks and Benefits of Indracaterol - The FDA's Review. N Engl J Med 2011;365:2247-9.
Dec 7, 2011 • 15min
NEJM Interview: Dr. Jerry Avorn on the evolving approach to drug safety in the United States
Dr. Jerry Avorn is Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Avorn J. Learning about the Safety of Drugs - A Half-Century of Evolution. N Engl J Med 2011;365:2151-3.
